International Business Machines (NYSE: IBM | IBM Price Prediction) is traded at $229.32 as of February 24, 2026, while the average analyst price target sits at $324.95. That is a gap of roughly 41.7% between where the stock trades and where Wall Street thinks it belongs. For a company of IBM’s scale and institutional ownership, that kind of dislocation demands explanation.
IBM is a more than a century old technology company that has spent the better part of the past decade repositioning itself around hybrid cloud and AI. Under CEO Arvind Krishna, the company shed its managed infrastructure business (spun off as Kyndryl in 2021) and doubled down on software, consulting, and its Watsonx AI platform. That transformation appeared to be working heading into 2026, with the stock up roughly 35% in 2025 and management raising guidance after a strong third quarter. Then the bottom fell out.
The 22.14% year-to-date decline through February 24 has erased those gains and then some. Two catalysts drove the collapse, and understanding them is essential to judging whether the current price is a bargain or a warning.
A 13% Single-Day Crash Triggered by an AI Threat to IBM’s Core Business
The most violent move came in a single session when Anthropic announced that its Claude Code tool is positioned as an ideal solution for code modernization, including COBOL legacy system work. That announcement hit IBM where it hurts most. A significant portion of IBM’s consulting revenue comes from exactly that kind of work: helping large enterprises modernize aging mainframe and legacy codebases. The market’s reaction was swift and severe. IBM fell roughly 13% in a single day, a drop that Reddit’s investing communities quickly labeled among IBM’s worst in decades.
The selloff was company-specific, not a broad tech rout. The concern is structural: if a general-purpose AI coding tool can automate COBOL modernization at a fraction of IBM’s consulting rates, the addressable market for IBM’s highest-margin services work shrinks. That fear was compounded by the fact that IBM’s consulting segment was already showing signs of deceleration. In Q3 2025, consulting revenue grew just 3% year-over-year to $5.3 billion, the weakest of IBM’s three main segments. Software grew 10% and infrastructure surged 17% in the same period, which raises the question of how much of IBM’s growth story depends on consulting holding its ground.
Adding to the pressure, broader macro uncertainty around new global tariffs has weighed on enterprise technology spending sentiment, giving investors another reason to reduce exposure to companies with large professional services revenue streams.
Analysts Are Holding Their Targets, Betting the AI Threat Is Overpriced by the Market
Despite the selloff, Wall Street has not abandoned IBM. Of 21 analysts tracked, 11 rate the stock a Buy or Strong Buy, seven hold a neutral stance, and just three are bearish. Jefferies maintained its Buy rating following the decline, and the consensus target of $324.95 implies the average analyst still sees the stock roughly doubling from its trough levels.
The bull thesis centers on a few durable pillars. IBM’s AI book of business reached $9.5 billion as of Q3 2025, and management raised its full-year free cash flow target to approximately $14 billion. IBM also beat both revenue and EPS estimates in each of its last two quarters, with prediction markets pricing a near-certain earnings beat for Q4 2025 as well, resolving at $0.999 on January 29, 2026. Analysts who are maintaining targets argue that IBM’s AI and hybrid cloud software business, not its consulting arm, is the real growth engine, and that the market is conflating a threat to one segment with an existential threat to the whole company.
The dividend also provides a floor of sorts. IBM pays $6.72 per share annually, representing a yield of roughly 3% at current prices, with the next payment scheduled for March 10, 2026.
Where Things Stand
Current Situation:
- Current Price: $229.32 (as of February 24, 2026)
- Average Analyst Target: $324.95
- Implied Upside: 41.7%
- Analysts Covering: 21
- YTD Performance: −22.14%
- One-Week Performance: −11.22%
- 52-Week Range: $214.50 to $324.90
- Dividend Yield: approximately 3.0%
Analyst Ratings Breakdown:
- Strong Buy: 2
- Buy: 9
- Hold: 7
- Sell: 2
- Strong Sell: 1
Comparison to S&P 500 YTD:
- IBM YTD: −22.14%
- S&P 500 YTD: broad market has held relatively flat in early 2026, a stark contrast to IBM’s decline
The consensus here is meaningful but not overwhelming. An 11-to-3 bullish-to-bearish split among analysts suggests real conviction, but the seven Hold ratings indicate a significant portion of the Street wants to see more evidence before committing. Analyst targets are not guarantees, and a 41.7% implied upside on a stock that has already fallen 22% in two months warrants healthy skepticism. It is also worth noting that insider activity during the selloff has been dominated by scheduled RSU vesting events rather than discretionary open-market purchases, which limits how much signal can be drawn from the acquisition numbers.
The Bull Case and the Bear Case
The bull case strengthens if the consulting threat from AI coding tools proves narrower than the market fears. IBM’s software segment, which grew 14% last quarter and houses Watsonx, is the higher-margin, more defensible business. If that segment continues to accelerate while consulting stabilizes or finds new AI-adjacent work to replace legacy modernization revenue, IBM’s trailing price-to-earnings ratio sits at roughly 21x on a company generating $14 billion in annual free cash flow with a 3% dividend yield, metrics analysts cite when discussing the stock’s current valuation.
The bear case intensifies if the Claude Code threat turns out to be the beginning of a broader commoditization of IBM’s services value proposition. Consulting already grew just 3% before this catalyst landed. If enterprise clients start routing code modernization work to AI tools rather than IBM’s consulting teams, the revenue impact compounds quickly across a $5-billion-per-quarter segment. The market is not wrong to price in that risk. It is asking whether IBM can pivot its consulting workforce toward higher-value AI implementation work fast enough to offset what it loses in legacy modernization.
The honest answer is that this is genuinely close to call. The fundamentals heading into 2026 were strong, the AI book of business is real, and the stock has declined sharply enough that analysts argue the risk is now reflected in the price, though that view is not universal. But the competitive threat is structural, not cyclical, and structural threats are harder to recover from than a bad quarter. The next two quarters of consulting revenue data will likely determine whether analysts or the market had the right read.
Top Gaining Stocks
Top Losing Stocks